DR AGARWALS EYE HOSPITAL
|
DR AGARWALS EYE HOSPITAL Last 5 Year Financial Ratios History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 98.64 | 78.55 | 51.28 | -3.06 | 29.11 |
| CEPS(Rs) | 155.26 | 121.49 | 94.66 | 37.58 | 74.29 |
| DPS(Rs) | 5.00 | 3.00 | 3.00 | - | - |
| Book NAV/Share(Rs) | 334.36 | 241.15 | 166.32 | 116.30 | 119.36 |
| Tax Rate(%) | 25.53 | 25.26 | 25.41 | 125.09 | 31.38 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 28.81 | 28.27 | 29.15 | 21.35 | 26.78 |
| EBIT Margin(%) | 22.10 | 21.42 | 19.64 | 9.08 | 16.21 |
| Pre Tax Margin(%) | 19.50 | 18.43 | 16.06 | 4.10 | 11.33 |
| PAT Margin (%) | 14.52 | 13.77 | 11.98 | -1.03 | 7.78 |
| Cash Profit Margin (%) | 22.85 | 21.30 | 22.11 | 12.63 | 19.85 |
| Performance Ratios | |||||
| ROA(%) | 9.63 | 9.78 | 9.63 | -0.86 | 9.55 |
| ROE(%) | 34.28 | 38.56 | 36.29 | -2.60 | 26.91 |
| ROCE(%) | 38.59 | 42.98 | 42.40 | 16.92 | 39.87 |
| Asset Turnover(x) | 0.66 | 0.71 | 0.80 | 0.84 | 1.23 |
| Sales/Fixed Asset(x) | 0.79 | 0.81 | 0.89 | 0.95 | 1.63 |
| Working Capital/Sales(x) | -4.19 | -5.38 | -6.24 | -5.32 | -18.14 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.27 | 1.23 | 1.13 | 1.06 | 0.61 |
| Receivable days | 13.17 | 12.78 | 15.83 | 20.30 | 15.98 |
| Inventory Days | 9.00 | 7.98 | 9.93 | 17.22 | 15.01 |
| Payable days | 316.97 | 320.55 | 347.24 | 351.93 | 238.56 |
| Valuation Parameters | |||||
| PER(x) | 31.46 | 11.65 | 14.26 | - | 6.56 |
| PCE(x) | 19.99 | 7.53 | 7.72 | 8.33 | 2.57 |
| Price/Book(x) | 9.28 | 3.80 | 4.39 | 2.69 | 1.60 |
| Yield(%) | 0.16 | 0.33 | 0.41 | - | - |
| EV/Net Sales(x) | 4.62 | 1.66 | 1.72 | 1.05 | 0.57 |
| EV/Core EBITDA(x) | 15.19 | 5.74 | 5.79 | 4.61 | 2.02 |
| EV/EBIT(x) | 20.92 | 7.76 | 8.77 | 11.55 | 3.52 |
| EV/CE(x) | 7.08 | 2.84 | 1.04 | 0.88 | 0.60 |
| M Cap / Sales | 4.57 | 1.60 | 1.71 | 1.05 | 0.51 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 19.10 | 33.24 | 43.92 | -20.54 | 3.47 |
| Core EBITDA Growth(%) | 25.17 | 29.56 | 88.44 | -36.12 | 55.74 |
| EBIT Growth(%) | 22.82 | 45.34 | 211.36 | -55.51 | 35.59 |
| PAT Growth(%) | 25.57 | 53.20 | 1,775.24 | -110.51 | 14.84 |
| EPS Growth(%) | 25.57 | 53.20 | 1,775.24 | -110.51 | 14.84 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.33 | 0.39 | 0.41 | 0.40 | 0.31 |
| Current Ratio(x) | 0.44 | 0.48 | 0.61 | 0.63 | 0.75 |
| Quick Ratio(x) | 0.37 | 0.42 | 0.54 | 0.55 | 0.55 |
| Interest Cover(x) | 8.50 | 7.14 | 5.48 | 1.82 | 3.32 |
| Total Debt/Mcap(x) | 0.04 | 0.10 | 0.09 | 0.15 | 0.20 |
Compare Financial Ratios of peers of DR AGARWALS EYE HOSPITAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR AGARWALS EYE HOSPITAL | ₹2,079.6 Cr | 1.2% | -1.6% | 10.1% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹122,782.0 Cr | -0.7% | 3.6% | 42.2% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹104,306.0 Cr | -0.3% | 0.9% | 8.5% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹69,516.5 Cr | 6.2% | 20.5% | 83.4% | Stock Analytics | |
| GLOBAL HEALTH | ₹37,283.9 Cr | 4.4% | 6.2% | 21% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹36,158.6 Cr | -2.1% | -11.8% | 41.8% | Stock Analytics | |
DR AGARWALS EYE HOSPITAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR AGARWALS EYE HOSPITAL | 1.2% |
-1.6% |
10.1% |
| SENSEX | -0.5% |
-3.1% |
1.4% |
You may also like the below Video Courses
